J0167 – Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0167
- Long description
- Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg
- Short description
- Inj epinephrine (hospira)
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- July 1, 2025
- Last change
- July 1, 2025 – No change
Frequently asked questions
What is HCPCS code J0167?
J0167 is a HCPCS Level II code for injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg.
Does Medicare cover J0167?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0150 – Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
- J0151 – Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
- J0153 – Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
- J0162 – Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg
- J0163 – Injection, epinephrine in sodium chloride (endo), 0.1 mg
- J0164 – Injection, epinephrine in sodium chloride (baxter), 0.1 mg
- J0165 – Injection, epinephrine, not otherwise specified, 0.1 mg
- J0166 – Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg
- J0168 – Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg
- J0169 – Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg
- J0171 – Injection, adrenalin, epinephrine, 0.1 mg
- J0172 – Injection, aducanumab-avwa, 2 mg
- J0173 – Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg
- J0174 – Lecanemab-irmb, for intravenous injection, 1 mg
- J0175 – Injection, donanemab-azbt, 2 mg
- J0177 – Injection, aflibercept hd, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.